Skip To Main Content
Teshamae Monteith on Muck Rack

Teshamae Monteith

Miami
As seen in: NEJM Clinician, Wiley Online Library, Frontiers, MDPI, Taylor & Francis Online, The Hill, U.S. News and World Report, The New England Journal of Medicine, Healio, Healio Neurology, Healio Primary Care and
Neurologist | Headache specialist Find me at @umiamineuro IHS, AHS, UCNS, AMF, AAN Advancing equitable headache care, education, research 🧠🙏🏽🌎🥬
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Teshamae

Contact Teshamae, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Efficacy of IV Fosphenytoin for Acute Attacks of Trigeminal Neuralgia

|
By Teshamae Monteith
| The New England Journal of Medicine Verified
Disclosures Consultant/Advisory BoardAbbVie; Axsome; Teva; Linpharma; e-Neura; Novartis; Merz; Lundbeck; Axsome; Pfizer. Unpaid co-author for collaborative research sponsored by AbbVie, Pfizer/Biohaven, and Theranica.
Open in Who Shared Issue with article?

STS101 nasal powder as a new treatment option for acute migraine with or without aura in adults

|
By Bradley Ong, Teshamae Monteith
| Taylor & Francis Online
ABSTRACT Introduction Although effective acute migraine therapies are available, unmet treatment needs such as nausea, vomiting, or delayed gastric emptying remain. STS101 is a novel dihydroergotamine (DHE) nasal powder designed to treat acute migraine with a simple single.
Open in Who Shared Issue with article?

Efficacy and safety of rimegepant for the acute treatment of migraine in Black or African American adults: A post hoc pooled subgroup analysis from three randomized, placebo‐controlled clinical trials - Charleston - Headache: The Journal of Head and Face

|
By Larry Charleston, Cynthia E. Armand Verified, Teshamae Monteith, Hope O'Brien
| Wiley Online Library Verified
AE adverse event BMI body mass index CGRP calcitonin gene-related peptide CI confidence interval MBS most bothersome symptom SD standard deviation INTRODUCTION In the United States, prevalence estimates for severe headaches or migraine are similar among Black or African American (14.5%) and White (15.5%) populations.1 There are, however, racial/ethnic discrepancies in migraine care.
Open in Who Shared Issue with article?
See all 30 articles